Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes

Diabetes Care. 2007 Jun;30(6):1577-8. doi: 10.2337/dc06-1998. Epub 2007 Mar 26.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Albuminuria
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Benzoates / therapeutic use*
  • Diabetic Nephropathies / physiopathology*
  • Diabetic Nephropathies / prevention & control*
  • Double-Blind Method
  • Humans
  • Middle Aged
  • Placebos
  • Telmisartan

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Placebos
  • Telmisartan